Hinge Health, Inc. engages in the development of technology platform for the treatment of musculoskeletal (MSK) conditions. Its platform addresses a broad spectrum of MSK care, from acute injury to chronic pain and to post-surgical rehabilitation. The company was founded by Daniel Perez and Gabriel Mecklenburg in 2014 and is headquartered in San Francisco, CA.
Clinical Trials
0
0 active
Approvals
0
Total approvals
Agencies
0
Regulatory bodies
Founded
N/A
No trial phase data available
No trial data available
No trial data available
No approval data available
- The global sensor-based digital therapeutics devices market is projected to grow from USD 249.6 million in 2026 to USD 590.9 million by 2036 at a 9.0% CAGR. - Software is expected to hold a 41.8% market share in 2026, reflecting its central role in interpreting sensor inputs and coordinating personalized interventions. - Hospitals are forecast to lead the care setting category at 28.0% share in 2026, driven by established clinical governance and escalation capacity. - India and China lead country-level growth at 12.2% and 11.3% CAGR respectively, supported by expanding digital health ecosystems and connected monitoring technologies.
- Hinge Health co-founder Gabriel Mecklenburg sold 50,000 Class A shares for approximately $3.28 million at a weighted average price of $65.54 per share in June 2026. - Insight Holdings Group sold 426,000 shares totaling $38.4 million at $90.21 per share in July 2026, though it retains indirect derivative securities. - The sales occurred against a backdrop of strong price appreciation, with the stock delivering a 101% one-year return as of July 9, 2026. - Hinge Health reported trailing twelve-month revenue of $646.3 million and a net loss of $510.3 million, with Q1 2026 sales jumping 47% year over year to $182 million.
- Omada Health, a virtual care provider for chronic conditions like diabetes and hypertension, has filed for an IPO with Q1 2025 revenue of $55 million, representing a 57% year-over-year increase. - The company has demonstrated improving financial health with narrowing losses, reporting a Q1 net loss of $9.4 million, down from $19 million in the same period last year. - Despite a challenging IPO environment following recent market turbulence, Omada serves over 679,000 members through 2,000+ employer partnerships, targeting the 156 million Americans with at least one chronic condition.
